Project Grant HT94252310709
Award Date
7/15/23
Completion Date
7/14/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Miami, FL 33136, USA
Similar Awards
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
This federal Project Grant award of $357,989.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Cincinnati focused on "MAGNETOPHOTOTHERMAL NANOPARTICLE DRUG DELIVERY FOR TREATING NOISE-INDUCED HEARING LOSS". The award period runs from September 1, 2025 to August 31, 2027. The Military Medical Research and Development program funds advanced biomedical research to transform healthcare for...
The Defense Health Agency has awarded a $1,370,529 Cooperative Agreement under the Military Medical Research and Development program (CFDA 12.420) to the Massachusetts Eye and Ear Infirmary. The funding supports a 3-year project to investigate the regeneration of synapses to treat synaptopathy (damage to synaptic connections) following noise exposure, with the goal of transforming healthcare for Service Members and the American public. As a sub-award under this grant, The Geneva Foundation...
This is a Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The $1,148,034.00 award, with a period of performance from September 15, 2024 to September 14, 2027, will fund the University of Illinois to develop objective biomarkers and novel treatment strategies for hidden hearing loss and hyperacusis. As a prominent research institution, the University of Illinois has extensive experience in conducting...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $371,627 to the University of Texas Medical Branch at Galveston (UTMB) to support research on "TARGETING RETINOID ACID METABOLIC PATHWAY TO TREAT NOISE-INDUCED HEARING LOSS". The research aims to investigate the use of selective CYP26 inhibitors as a treatment for noise-induced hearing loss, with potential to transform care for Service Members and...
This $1,170,000.00 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) funds research by the Regents of the University of Michigan to develop systemically administered bispecific antibodies that activate neurotrophin receptors for treating noise-induced inner ear damage. The award period runs from May 15, 2025 to May 14, 2028. The University of Michigan, a prominent U.S. state government-owned educational...
The U.S. Department of Defense awarded a $350,848 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan to fund a 2-year research project titled "A Novel Strategy to Prevent Central Auditory Disorders After Blast Exposure." The project aims to develop a nanoparticle-based delivery system to administer therapeutics that can prevent hearing loss and other auditory impairments resulting from blast exposures...
The Department of the Army Medical Command awarded a $1,437,602 Project Grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support development of novel gene and RNA therapies to prevent and restore noise-induced hearing loss. Specifically, researchers will develop long-term gene therapy and short-term siRNA products targeting the NOX3 pathway and validate efficacy and safety in auditory...